Searched for
CONCORD BIOTECH LISTING DAY GAINS
SoftBank completes second $10 billion tranche of its $30 billion OpenAI investmentSoftBank has injected another $10 billion into OpenAI, part of a larger $30 billion commitment. This significant investment, funded by a br...- Aastha Spintex IPO Day 3: Issue subscribed 3 times; Check GMP and other details. Should you apply?The company plans to deploy the IPO proceeds to acquire Falcon Yarns, meet working capital requirements, and support general corporate purp...
- Advit Jewels share price slides 5% after strong 37% market debut. Should you buy, sell or hold?Advit Jewels shares made a strong stock market debut, listing at a 37% premium to the IPO price before trimming gains. While analysts remai...
- 6 IPOs open for subscription with GMPs up to 28%. Check all detailsThe fresh offerings come amid mixed investor interest in the SME segment, although listing performance has remained muted in recent weeks, ...
- Aastha Spintex IPO Day 2: GMP signals 4% listing gain; subscription nears full. Should you apply?Aastha Spintex's Rs 170 crore IPO entered Day 2 with a 4% grey market premium (GMP), indicating a potential listing around Rs 141 versus th...
- US stocks today: US stocks end higher as Iran tensions ease; major tech-related shares jumpUS stocks closed sharply higher with the Dow hitting a record close as easing US-Iran tensions lifted sentiment. Tech stocks led gains, wit...
- Aastha Spintex IPO off to a steady start; issue subscribed 52% on Day 1. Check GMP & key detailsAastha Spintex IPO saw a steady start on Day 1, subscribed 52% by mid-session, with strong NII demand leading the response. The issue carri...
- CSM Technologies IPO fully subscribed on final day; GMP hints at 4% listing gain. Should you subscribe?CSM Technologies' IPO successfully crossed the finish line, fully subscribed on its final day, driven by strong retail investor interest. T...
- Dollar declines for second straight day but set for weekly gainThe dollar dipped for a second day as easing inflation and falling oil prices tempered expectations for Federal Reserve rate hikes. Despite...
- Over 200x subscription! Advit Jewels becomes the hottest IPO of 2026; GMP at 41%Advit Jewels’ IPO closed with a blockbuster 212.62 times subscription, making it the most sought-after issue of 2026 so far. Strong demand ...
- Advit Jewels IPO Day 3: Issue subscribed 213x on strong retail, NII demand; GMP hints at 40% listing gainsJaipur's Advit Jewels IPO is witnessing overwhelming investor interest, subscribed over 212 times by day three, with a significant 40% grey...
- US Stocks | Nasdaq futures surge 2% as chip outlook calms AI jitters; inflation data awaitedIndian markets are set for a positive opening as US futures surged, led by a 2.24% jump in the Nasdaq. Memory chip giants Micron and Qualco...
- Waterways Leisure Tourism IPO Day 3: Issue subscribed 69%, GMP signals flat debut. Should you apply?Waterways Leisure Tourism IPO: The IPO received a lukewarm response on its final day of bidding, with the issue subscribed only 69% overall...
- CSM Technologies IPO Day 2 update: Subscribed 32%, GMP at 4%. Should you subscribe?CSM Technologies' IPO is seeing a subdued response on its second day, with only 32% subscription. Retail investors show more interest, subs...
- Advit Jewels IPO Day 2: Issue subscribed over 20x, GMP signals 41% listing gains. Should you bid?Jaipur-based Advit Jewels' IPO is seeing massive investor interest, subscribed over 20 times on day two with a strong grey market premium. ...
- Waterways Leisure Tourism IPO Day 2: GMP signals flat debut - Should you apply?Waterways Leisure Tourism IPO entered Day 2 with weak investor demand and a GMP of around 1%, signalling a flat listing outlook. Subscripti...
- US stocks today: S&P 500, Dow tick higher as investors weigh Mideast negotiationsWall Street's major indexes opened little changed on Monday as investors returned from the long holiday weekend and awaited clarity on US-I...
- Two Trades for Today: A maker of forged components for a 7.7% gain, a mid-cap pharma stock for a 6% upmoveOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
Load More
